相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Rohann J. M. Correa et al.
RADIOTHERAPY AND ONCOLOGY (2022)
HDR brachytherapy as monotherapy for prostate cancer: A systematic review with meta-analysis
Gustavo Arruda Viani et al.
BRACHYTHERAPY (2021)
Ultra-hypofractionated radiotherapy for low- and intermediate risk prostate cancer: High-dose-rate brachytherapy vs stereotactic ablative radiotherapy
Yat Man Tsang et al.
RADIOTHERAPY AND ONCOLOGY (2021)
High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up
Manuel Behmueller et al.
FRONTIERS IN ONCOLOGY (2021)
Prostate high dose -rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy
Gerard Morton et al.
RADIOTHERAPY AND ONCOLOGY (2020)
A biochemical definition of cure after brachytherapy for prostate cancer
Juanita M. Crook et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Long-Term Prostate Specific Antigen Stability and Predictive Factors of Failure after Permanent Seed Prostate Brachytherapy
Audrey Tetreault-Laflamme et al.
JOURNAL OF UROLOGY (2018)
High dose rate brachytherapy for prostate cancer: A prospective toxicity evaluation of a one day schedule including two 13.5 Gy fractions
Gorka Nagore et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
W. James Morris et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer
Peter Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2017)
High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current Status
N. Tselis et al.
CLINICAL ONCOLOGY (2017)
High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success
Joelle Helou et al.
RADIOTHERAPY AND ONCOLOGY (2015)
High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer
Ricardo Cendales et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2015)
Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival
Andrea C. Lo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity Data
Michel Ghilezan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
DOSE ESCALATION IMPROVES CANCER-RELATED EVENTS AT 10 YEARS FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH HYPOFRACTIONATED HIGH-DOSE-RATE BOOST AND EXTERNAL BEAM RADIOTHERAPY
Alvaro A. Martinez et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
分享论文
